The relationship between pharmacokinetic variables and pharmacodynamic profiles of bolus versus continuous infusion of furosemide in critically ill patients

Daru

Volumn 13, Issue 3, 2005, Pages 127-132

  Mojtahedzadeh, Mojtaba ^a   Ardakani, Maria Tavakoli ^a   Salehifar, Ebrahim ^a   Najafi, Atabak ^b   Khajavi, Mohammad Reza ^b   Moeini, Majid ^b   Sadray, Sima ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bolus; Furosemide; Infusion; Pharmacodynamic; Pharmacokinetics

Indexed keywords

FUROSEMIDE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICALLY ILL PATIENT; DIURETIC ACTIVITY; DRUG DOSE REGIMEN; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PLASMA CLEARANCE; POTASSIUM BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SODIUM BLOOD LEVEL; STATISTICAL SIGNIFICANCE; URINE VOLUME;

EID: 31544461542     PISSN: 15608115     EISSN: 15608115     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Schuller D, Lynch JP, Fine D. Protocol guided diuretic management: Comparison of furosemide by continuous infusion and intermittent bolus. Crit Care Med 1997; 25: 1969-1975.
2. Schuller D, Mitchell JP, Calandrino FS, Schuster DP. Fluid balance during pulmonary edema. Is fluid gain a marker or a cause of poor outcome. Chest 1991; 100: 1068-1075.
3. Humprey H, Hall J, Sznajder I. Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest 1990; 97: 1176-1180.
4. Kaojaren S, Day B, Brater DC. The time course of delivery of furosemide into the urine: an independent determinant of overall response. Kidney Int 1982; 22: 69-74.
5. Lee MG, Li T, Chiou WL. Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of furosemide. Biopharm Drug Dispos 1986; 7: 537-47.
6. Alvan G, Helleday L, Lindholm A, Sanz E, Villen T. Diuretic effect and diuretic efficiency after intravenous dosage of furosemide. Br J Clin Pharm 1990; 29: 215-90.
7. Brater DC. Pharmacodynamic considerations in the use of diuretics. Ann Rev Pharmacol Toxicol 1983; 23: 24-62.
8. Lawson DH, Gray JMB, Henry DA, Tilstone WJ. Continuous infusion of furosemide in refractory edema. BMJ 1978; 2: 476.
9. Castaneda - Hernandez G, Verges J, Pichette V, Heroux L, Caille G, Du-souich P. Input rate as a major determinant of furosemide pharmacodynamics: influence of fluid replacement and hypoalbuminemia. Drug Metab Dispos 2000; 28: 323-328.
10. Van Meyel JJM, Smiths P, Russel FGM, Gerlag PGG, Tan Y, Gribnav FWT. Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers. Clin Pharmacol Ther 1992; 51: 440-444.
11. Wakelkamp M, Alvan G, Paintaud G. Natriuretic efficieny of furosemide as a consequence of drug input rate. Br J Clin Pharmacol 1997; 43: 481-491.
12. Tilstone WJ, Fine A. Furosemide kinetics in renal failure. Clin Pharmacol Ther 1978; 23: 644-650.
13. Beerman B, Dalen E, Lindstrom B. Elimination of furosemide in healthy subjects and in those with renal failure. Clin Pharmacol Ther 1977; 22: 70-78.
14. Brater DC, Seiwell R, Anderson S, Burdette A, Dehmer GJ, Chennavasin P. Absorption and disposition of furosemide in congestive heart failure. kidney Int 1982; 22: 171-176.
15. Kerremans AL, Tan Y, Van Baar H, Van Ginneken CAM, Gribnau FWJ. Furosemide kinetics and dynamics in aged patients. Clin Pharmacol Ther 1983; 34: 181-189.
16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829.
17. Barroso MB, Jimenez RM, Alonso RM, Ortiz E. Determination of piretanide and furosemide in pharmaceuticals and human urine by high - performance liquid chromatography with amperometric detection. J Chrom B 1996; 675: 303-312.
18. Abou - Auda HS, Al - Yamani MJ, Morad AM, Bawazir SA, Khan SZ, Al - Khamis KI. High - performance liquid chromatographic determination of furosemide in plasma and urine and its use in bioavailability studies. J Chromatogr B 1998; 710: 121-128.
19. Vargo DL, Kramer WG, Black PK, Smith WB, Serpas T, Brater DC. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther 1995; 57: 601-609.
20. Krasna MJ, Scott GE, Scholz PM. Postoperative enhancement of urinary output in patients with acute renal failure using continuous furosemide therapy. Chest 1986; 89: 294-295.
21. Rudy DW, Voelker JR, Green PK. Loop diuretics for chronic renal insufficiency. A continuous infusion is more efficacious than bolus therapy. Ann Intern Med 1991; 115: 360-366.
22. Copeland JG, Campbell DW, Plachetka JR, Salmon NW, Larson DF. Diuresis with continuous infusion of furosemide after cardiac surgery. Am J Surg 1983; 146: 796-90.
23. Magovern JA, Magovern GJ. Diuresis in hemodynamically compromised patients continuous furosemide infusion. Ann Thorac Surg 1990; 50: 482-484.
24. Klinge JM, Scharf J, Tlofbeck M, Gerling S, Bonakdar S, Singer H. Intermittent administration of furosemide versus continuous infusion in the postoperative management of children following open heart surgery. Intensive Care Med 1997; 23: 693-697.
25. Alvan G, Paintaud G, Wakelkamp M. The efficiency concept in pharmacodynamics. Clin Pharmacokinet 1999; 36: 75-389.